Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé

1 result

  • Active substance : erlotinib
  • Topics : Methodology
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Methodology (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Drug therapy (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Methodology guide (1)
Langue
  • Français (1)
Substance active
  • aspirine (1)
  • clopidogrel (1)
  • erlotinib (1)
  • mauve (1)
  • panitumumab (1)
  • trastuzumab (1)
  • tyrosine (1)
More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Companion diagnostic test associated with a targeted therapy: definitions and assessment method

    Methodology guide - Posted on 7/4/2014
    Download guide
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
X6x2ghq60yxvY5WN